Discontinued — last reported Q4 '25
This is a positive signal — lower values indicate better performance for this metric.
High levels of cashless exercise indicate dilution of existing shareholders without providing new cash capital to the company.
A non-cash transaction where warrant holders exchange their warrants for common stock without a cash payment to the comp...
Common in biotech and tech sectors; often disclosed in the non-cash activity section of the cash flow statement.
other_cashless_exercise_of_the_company_common_stock_warrants| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | -$20.81M | -$20.81M | -$20.81M | -$20.81M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | +0.0% | +0.0% | +0.0% | +100.0% | — | — | — | — | — |
| YoY Change | — | — | — | — | — | — | +100.0% | +100.0% | — | — | — | — |